| Catalog Number |
195-100 |
| Medical Device Problem Code |
Non Reproducible Results (4029)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
01/04/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The remainder of the investigation remains in progress.A supplemental report will be provided after completion.
|
| |
|
Event or Problem Description
|
|
The consumer reported conflicting results with two binaxnow covid-19 home tests performed.The first test generated a positive result.The repeat test generated a negative result.No additional patient information, including treatment and outcome, was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
The remainder of the investigation remains in progress.A supplemental report will be provided after completion.
|
| |
|
Event or Problem Description
|
|
The consumer reported conflicting results with two binaxnow covid-19 home tests performed.The first test generated a positive result.The repeat test generated a negative result.No additional patient information, including treatment and outcome, was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 148660 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-100/195-200/ lot 148660 and device part number 195-430h / lot 143676.Quality control release testing met specifications and there were no conflicting results observed.The current overall incident rate for false positive patient results (confirmed and unconfirmed, conflicting results) for this specific lot based on the total quantity of devices manufactured for distribution is (b)(4).The current overall incident rate for false negative patient results (confirmed and unconfirmed, conflicting results) for this specific lot based on the total quantity of devices manufactured for distribution is (b)(4).Abbott diagnostics scarborough was unable to determine an assignable root cause, however, a possible assignable root cause is patient sample interference.Substances in the sample itself may have interfered with the reaction.Based on the above summary, the investigation is deemed complete.
|
| |
|
Search Alerts/Recalls
|